Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 375

1.

Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.

Berghausen EM, Feik L, Zierden M, Vantler M, Rosenkranz S.

Herz. 2019 Mar 7. doi: 10.1007/s00059-019-4795-6. [Epub ahead of print]

PMID:
30847510
2.

Sources of variability and accuracy of performance assessment in the clinical pharmacology quality assurance (CPQA) proficiency testing program for antiretrovirals.

Browne RW, Rosenkranz SL, Wang Y, Taylor CR, DiFrancesco R, Morse GD.

Ther Drug Monit. 2019 Feb 20. doi: 10.1097/FTD.0000000000000612. [Epub ahead of print]

PMID:
30829950
3.

Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.

Kramer T, Dumitrescu D, Gerhardt F, Orlova K, Ten Freyhaus H, Hellmich M, Baldus S, Rosenkranz S.

Int J Cardiol. 2019 Jan 4. pii: S0167-5273(18)35398-1. doi: 10.1016/j.ijcard.2018.12.078. [Epub ahead of print]

PMID:
30777406
4.

EXPRESS: High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation.

Hohmann C, Dumitrescu D, Gerhardt F, Kramer T, Rosenkranz S, Huntgeburth M.

Pulm Circ. 2019 Feb 15:2045894019835649. doi: 10.1177/2045894019835649. [Epub ahead of print] No abstract available.

PMID:
30767601
5.

High-Fat Meal-Induced Changes in Markers of Inflammation and Angiogenesis in Healthy Adults Who Differ by Age and Physical Activity Level.

Emerson SR, Sciarrillo CM, Kurti SP, Emerson EM, Rosenkranz SK.

Curr Dev Nutr. 2018 Nov 30;3(1):nzy098. doi: 10.1093/cdn/nzy098. eCollection 2019 Jan.

6.

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C.

PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

7.

Pulmonary hypertension due to left heart disease.

Vachiéry JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, Coghlan G, Chazova I, De Marco T.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801897. doi: 10.1183/13993003.01897-2018. Print 2019 Jan.

8.

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.

Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF.

Int J Cardiol. 2018 Dec 1;272S:53-62. doi: 10.1016/j.ijcard.2018.08.080. Epub 2018 Aug 27.

PMID:
30527996
9.

Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire.

Bjerre J, Rosenkranz SH, Christensen AM, Schou M, Jøns C, Gislason G, Ruwald AC.

BMC Cardiovasc Disord. 2018 Nov 20;18(1):212. doi: 10.1186/s12872-018-0949-3.

10.

Cologne consensus conference on pulmonary hypertension - Update 2018.

Rosenkranz S, Ghofrani HA, Grünig E, Klose H, Olschewski H, Hoeper MM.

Int J Cardiol. 2018 Dec 1;272S:1-3. doi: 10.1016/j.ijcard.2018.09.064. Epub 2018 Sep 22. No abstract available.

PMID:
30344062
11.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
12.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
13.

Impact of online, video-based wellness training on Girl Scout leaders' wellness promotion self-efficacy, intention, and knowledge: A pilot randomized controlled trial.

Cull BJ, Rosenkranz SK, Rosenkranz RR.

AIMS Public Health. 2018 Jul 6;5(3):225-234. doi: 10.3934/publichealth.2018.3.225. eCollection 2018.

14.

Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).

Huntgeburth M, Kießling J, Weimann G, Wilberg V, Saleh S, Hunzelmann N, Rosenkranz S.

Clin Drug Investig. 2018 Nov;38(11):1061-1069. doi: 10.1007/s40261-018-0698-1.

PMID:
30238433
15.

[Telemonitoring and pulmonary artery pressure-guided treatment of heart failure].

Angermann CE, Rosenkranz S.

Internist (Berl). 2018 Oct;59(10):1041-1053. doi: 10.1007/s00108-018-0495-1. Review. German.

PMID:
30238134
16.

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Hoeper MM, Apitz C, Grünig E, Halank M, Ewert R, Kaemmerer H, Kabitz HJ, Kähler C, Klose H, Leuchte H, Ulrich S, Olsson KM, Distler O, Rosenkranz S, Ghofrani HA.

Int J Cardiol. 2018 Dec 1;272S:37-45. doi: 10.1016/j.ijcard.2018.08.082. Epub 2018 Aug 25.

PMID:
30190158
17.

Variation in Nutritional Quality of School Lunches With Implementation of National School Lunch Program Guidelines.

Joyce JM, Rosenkranz RR, Rosenkranz SK.

J Sch Health. 2018 Sep;88(9):636-643. doi: 10.1111/josh.12665.

PMID:
30133780
18.

Many Kansas Worksites Offer Few Interventions to Reduce Occupational Sedentary Behavior.

Ablah E, Grilliot E, Okut H, Mailey EL, Rosenkranz SK, Rosenkranz RR.

Int J Environ Res Public Health. 2018 Aug 14;15(8). pii: E1745. doi: 10.3390/ijerph15081745.

19.

Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical Issues.

D'Alto M, Dimopoulos K, Coghlan JG, Kovacs G, Rosenkranz S, Naeije R.

Heart Fail Clin. 2018 Jul;14(3):467-477. doi: 10.1016/j.hfc.2018.03.011. Review.

PMID:
29966642
20.

Long-Term Dose-Response Condensed Tannin Supplementation Does Not Affect Iron Status or Bioavailability.

Delimont NM, Fiorentino NM, Kimmel KA, Haub MD, Rosenkranz SK, Lindshield BL.

Curr Dev Nutr. 2017 Sep 11;1(10):e001081. doi: 10.3945/cdn.117.001081. eCollection 2017 Oct.

21.

The relation of local order to material properties in relaxor ferroelectrics.

Krogstad MJ, Gehring PM, Rosenkranz S, Osborn R, Ye F, Liu Y, Ruff JPC, Chen W, Wozniak JM, Luo H, Chmaissem O, Ye ZG, Phelan D.

Nat Mater. 2018 Aug;17(8):718-724. doi: 10.1038/s41563-018-0112-7. Epub 2018 Jun 25.

PMID:
29941922
22.

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.

Stoessel D, Stellmann JP, Willing A, Behrens B, Rosenkranz SC, Hodecker SC, Stürner KH, Reinhardt S, Fleischer S, Deuschle C, Maetzler W, Berg D, Heesen C, Walther D, Schauer N, Friese MA, Pless O.

Front Hum Neurosci. 2018 Jun 4;12:226. doi: 10.3389/fnhum.2018.00226. eCollection 2018.

23.

Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.

Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug.

24.

Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase.

Klinke A, Berghausen E, Friedrichs K, Molz S, Lau D, Remane L, Berlin M, Kaltwasser C, Adam M, Mehrkens D, Mollenhauer M, Manchanda K, Ravekes T, Heresi GA, Aytekin M, Dweik RA, Hennigs JK, Kubala L, Michaëlsson E, Rosenkranz S, Rudolph TK, Hazen SL, Klose H, Schermuly RT, Rudolph V, Baldus S.

JCI Insight. 2018 Jun 7;3(11). pii: 97530. doi: 10.1172/jci.insight.97530. eCollection 2018 Jun 7.

25.

Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Angermann CE, Assmus B, Anker SD, Brachmann J, Ertl G, Köhler F, Rosenkranz S, Tschöpe C, Adamson PB, Böhm M.

Clin Res Cardiol. 2018 Nov;107(11):991-1002. doi: 10.1007/s00392-018-1281-8. Epub 2018 May 19.

PMID:
29777373
26.

Implementation of cross correlation for energy discrimination on the time-of-flight spectrometer CORELLI.

Ye F, Liu Y, Whitfield R, Osborn R, Rosenkranz S.

J Appl Crystallogr. 2018 Mar 26;51(Pt 2):315-322. doi: 10.1107/S160057671800403X. eCollection 2018 Apr 1.

27.

Risk assessment in pulmonary arterial hypertension.

Hoeper MM, Pittrow D, Opitz C, Gibbs JSR, Rosenkranz S, Grünig E, Olsson KM, Huscher D.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702606. doi: 10.1183/13993003.02606-2017. Print 2018 Mar. No abstract available.

PMID:
29599117
28.

Wellness-Promoting Practices Through Girl Scouts: A Pragmatic Superiority Randomized Controlled Trial With Additional Dissemination.

Cull BJ, Dzewaltowski DA, Guagliano JM, Rosenkranz SK, Knutson CK, Rosenkranz RR.

Am J Health Promot. 2018 Sep;32(7):1544-1554. doi: 10.1177/0890117118754825. Epub 2018 Jan 29.

PMID:
29378416
29.

Coherent band excitations in CePd3: A comparison of neutron scattering and ab initio theory.

Goremychkin EA, Park H, Osborn R, Rosenkranz S, Castellan JP, Fanelli VR, Christianson AD, Stone MB, Bauer ED, McClellan KJ, Byler DD, Lawrence JM.

Science. 2018 Jan 12;359(6372):186-191. doi: 10.1126/science.aan0593.

PMID:
29326267
30.

Postprandial Metabolic Responses Differ by Age Group and Physical Activity Level.

Emerson SR, Kurti SP, Emerson EM, Cull BJ, Casey K, Haub MD, Rosenkranz SK.

J Nutr Health Aging. 2018;22(1):145-153. doi: 10.1007/s12603-017-0956-6.

PMID:
29300434
31.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.

McLaughlin VV, Jansa P, Nielsen-Kudsk JE, Halank M, Simonneau G, Grünig E, Ulrich S, Rosenkranz S, Gómez Sánchez MA, Pulido T, Pepke-Zaba J, Barberá JA, Hoeper MM, Vachiéry JL, Lang I, Carvalho F, Meier C, Mueller K, Nikkho S, D'Armini AM.

BMC Pulm Med. 2017 Dec 28;17(1):216. doi: 10.1186/s12890-017-0563-7.

32.

Older women exhibit greater airway 8-isoprostane responses to strenuous exercise compared with older men and younger controls.

Kurti SP, Emerson SR, Smith JR, Rosenkranz SK, Alexander SA, Lovoy GM, Harms CA.

Appl Physiol Nutr Metab. 2018 May;43(5):497-503. doi: 10.1139/apnm-2017-0565. Epub 2017 Dec 14.

PMID:
29241018
33.

REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.

Benza RL, Farber HW, Frost A, Ghofrani HA, Gómez-Sánchez MA, Langleben D, Rosenkranz S, Busse D, Meier C, Nikkho S, Hoeper MM.

J Heart Lung Transplant. 2018 Apr;37(4):513-519. doi: 10.1016/j.healun.2017.11.006. Epub 2017 Nov 11.

34.

Local Orthorhombicity in the Magnetic C_{4} Phase of the Hole-Doped Iron-Arsenide Superconductor Sr_{1-x}Na_{x}Fe_{2}As_{2}.

Frandsen BA, Taddei KM, Yi M, Frano A, Guguchia Z, Yu R, Si Q, Bugaris DE, Stadel R, Osborn R, Rosenkranz S, Chmaissem O, Birgeneau RJ.

Phys Rev Lett. 2017 Nov 3;119(18):187001. doi: 10.1103/PhysRevLett.119.187001. Epub 2017 Oct 30.

35.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

PMID:
29167297
36.

Acute and long-term effects of fingolimod on heart rhythm and heart rate variability in patients with multiple sclerosis.

Akbulak RÖ, Rosenkranz SC, Schaeffer BN, Pinnschmidt HO, Willems S, Heesen C, Hoffmann BA.

Mult Scler Relat Disord. 2018 Jan;19:44-49. doi: 10.1016/j.msard.2017.10.020. Epub 2017 Nov 2.

PMID:
29127856
37.

Pulmonary vascular indices and survival in left heart disease: illusion of conclusion?

Rosenkranz S, Hoeper MM.

Eur J Heart Fail. 2018 Feb;20(2):256-259. doi: 10.1002/ejhf.1022. Epub 2017 Oct 19. No abstract available.

38.

ER stress-induced aggresome trafficking of HtrA1 protects against proteotoxicity.

Gerhardt MJ, Marsh JA, Morrison M, Kazlauskas A, Khadka A, Rosenkranz S, DeAngelis MM, Saint-Geniez M, Jacobo SMP.

J Mol Cell Biol. 2017 Dec 1;9(6):533. doi: 10.1093/jmcb/mjx040. No abstract available.

PMID:
29040612
39.

Low clinical conversion rate in clinically isolated syndrome patients - diagnostic benefit of McDonald 2010 criteria?

Rosenkranz SC, Kaulen B, Neuhaus A, Siemonsen S, Köpke S, Daumer M, Stellmann JP, Heesen C.

Eur J Neurol. 2018 Feb;25(2):247-e9. doi: 10.1111/ene.13476. Epub 2017 Dec 2.

PMID:
29024243
40.

ER stress-induced aggresome trafficking of HtrA1 protects against proteotoxicity.

Gerhardt MJ, Marsh JA, Morrison M, Kazlauskas A, Khadka A, Rosenkranz S, DeAngelis MM, Saint-Geniez M, Jacobo SMP.

J Mol Cell Biol. 2017 Dec 1;9(6):516-532. doi: 10.1093/jmcb/mjx024.

41.

Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.

Hummel YM, Liu LCY, Lam CSP, Fonseca-Munoz DF, Damman K, Rienstra M, van der Meer P, Rosenkranz S, van Veldhuisen DJ, Voors AA, Hoendermis ES.

Eur J Heart Fail. 2017 Dec;19(12):1651-1660. doi: 10.1002/ejhf.957. Epub 2017 Oct 6.

42.

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.

Hoeper MM, Simonneau G, Corris PA, Ghofrani HA, Klinger JR, Langleben D, Naeije R, Jansa P, Rosenkranz S, Scelsi L, Grünig E, Vizza CD, Chang M, Colorado P, Meier C, Busse D, Benza RL.

Eur Respir J. 2017 Sep 9;50(3). pii: 1602425. doi: 10.1183/13993003.02425-2016. Print 2017 Sep.

43.

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s.

Kiser JJ, Lu D, Rosenkranz SL, Morse GD, DiFrancesco R, Sherman KE, Butt AA; ACTG A5309s study team.

Drugs R D. 2017 Dec;17(4):557-567. doi: 10.1007/s40268-017-0205-9.

44.

Living With Hepatocellular Carcinoma Near the End of Life: Family Caregivers' Perspectives.

Hansen L, Rosenkranz SJ, Wherity K, Sasaki A.

Oncol Nurs Forum. 2017 Sep 1;44(5):562-570. doi: 10.1188/17.ONF.562-570.

PMID:
28820518
45.

Effects of an Intervention to Reduce Sitting at Work on Arousal, Fatigue, and Mood Among Sedentary Female Employees: A Parallel-Group Randomized Trial.

Mailey EL, Rosenkranz SK, Ablah E, Swank A, Casey K.

J Occup Environ Med. 2017 Dec;59(12):1166-1171. doi: 10.1097/JOM.0000000000001131.

PMID:
28816735
46.

What can we learn from pulmonary function testing in heart failure?

Magnussen H, Canepa M, Zambito PE, Brusasco V, Meinertz T, Rosenkranz S.

Eur J Heart Fail. 2017 Oct;19(10):1222-1229. doi: 10.1002/ejhf.946. Epub 2017 Aug 14. Review.

47.

Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension.

Nagel C, Ewert R, Egenlauf B, Lehmkuhl HB, Rosenkranz S, Benjamin N, Schwenger V, Herth FJF, Grünig E.

Respiration. 2017;94(3):263-271. doi: 10.1159/000478744. Epub 2017 Aug 5.

48.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug.

49.

Salivary proline-rich protein may reduce tannin-iron chelation: a systematic narrative review.

Delimont NM, Rosenkranz SK, Haub MD, Lindshield BL.

Nutr Metab (Lond). 2017 Jul 24;14:47. doi: 10.1186/s12986-017-0197-z. eCollection 2017. Review.

50.

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.

Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Faragon C, Malik M, Mendes RE, Jones RN, McNutt LA, Lodise TP.

BMC Infect Dis. 2017 Aug 2;17(1):534. doi: 10.1186/s12879-017-2609-0.

Supplemental Content

Loading ...
Support Center